Your browser doesn't support javascript.
loading
Efficacy and tolerability of abatacept treatment: results of 12 months observation.
Borisova, M A; Lukina, G V; Sigidin, Y A; Aronova, E S; Luchihina, E L; Karateev, D E; Glukhova, S V; Nasonov, E L.
Afiliação
  • Borisova MA; V.A. Nasonova Research Institute of Rheumatology, laboratory of monitoring safety of antirheumatic treatment, Moscow, Russia.
  • Lukina GV; V.A. Nasonova Research Institute of Rheumatology, laboratory of monitoring safety of antirheumatic treatment, Moscow, Russia.
  • Sigidin YA; Moscow Clinical Scientific Center named after Loginov A.S., Moscow, Russia.
  • Aronova ES; V.A. Nasonova Research Institute of Rheumatology, laboratory of monitoring safety of antirheumatic treatment, Moscow, Russia.
  • Luchihina EL; V.A. Nasonova Research Institute of Rheumatology, laboratory of monitoring safety of antirheumatic treatment, Moscow, Russia.
  • Karateev DE; Rheumatology, Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia.
  • Glukhova SV; Rheumatology, Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia.
  • Nasonov EL; V.A. Nasonova Research Institute of Rheumatology, laboratory of monitoring safety of antirheumatic treatment, Moscow, Russia.
Ter Arkh ; 90(5): 44-49, 2018 May 11.
Article em En | MEDLINE | ID: mdl-30701888

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Produtos Biológicos / Antirreumáticos / Abatacepte Limite: Female / Humans / Middle aged Idioma: En Revista: Ter Arkh Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Produtos Biológicos / Antirreumáticos / Abatacepte Limite: Female / Humans / Middle aged Idioma: En Revista: Ter Arkh Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Federação Russa